Ayman Saad

Academic / Other · 2 registered clinical trials.

Status	Trial	Phase	Started
Withdrawn	Avatrombopag for the Treatment of Thrombocytopenia After Donor Hematopoietic Stem Cell Transplant Platelet Disorder	Phase 2	2022-12-01
Completed	Safety of Post-transplant Alpha-beta Depleted T-cell Infusion Following Haploidentical Stem Cell Transplant (H Hematologic Neoplasms, Graft-Versus-Host Disease	N/A	2014-10-09